simpleABI-Q | Stand-Alone Rapid PAD Screening System (Doppler-Free PVR)
Best for: High-volume screening environments, diabetic foot clinics, and practices needing fast, staff-driven PAD assessments without Doppler expertise
Fast, Accessible PAD Screening — Without Doppler
The simpleABI-Q is a Doppler-free rapid PAD screening system that uses Pulse Volume Recording (PVR) technology to deliver quick, repeatable vascular assessments.
It is designed for practices that need speed, simplicity, and staff efficiency, allowing virtually any trained team member to perform the test—no Doppler experience required.
Unlike Doppler-based ABI systems, the simpleABI-Q focuses on rapid detection, making it ideal for identifying at-risk patients who require further evaluation.
Screen First. Confirm with Doppler
The simpleABI-Q is not a replacement for diagnostic ABI testing — it is the first step in vascular assessment:
- Use the simpleABI-Q to screen broadly and quickly
- Refer abnormal or borderline results for Doppler-based confirmation
For gold standard diagnostic confirmation recognized by the American Heart Association (AHA) and American College of Cardiology (ACC):

- simpleABI-250 — portable manual Doppler ABI
- simpleABI-400CL — Doppler-based Cuff-Link system with optional ABI-Q software
Why Choose PVR-Based Screening?
Pulse Volume Recording (PVR) evaluates blood flow by measuring volume changes in the limb, rather than relying on arterial pressure detection. Key advantages:
- Works in patients with calcified arteries (common in diabetes)
- No Doppler signal required
- Consistent, operator-independent results
- Fast test times for high patient throughput
Clinical relevance: Especially valuable in diabetic, podiatry, and primary care settings.





Our ultrasound products are made near Denver, Colorado, a well-known place for diagnostic ultrasound products. Each of our products, including probes, undergoes thorough inspection and testing, guaranteeing quality and durability. Our veteran team brings decades of experience in the vascular industry, further enhancing our products’ reliability.














